William Okoniewski, MD | |
1200 S Cedar Crest Blvd Fl 6, Allentown, PA 18103-6202 | |
(610) 402-7712 | |
Not Available |
Full Name | William Okoniewski |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 1200 S Cedar Crest Blvd Fl 6, Allentown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073197349 | NPI | - | NPPES |
MT222492 | Other | PA | GRADUATE MEDICAL TRAINEE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MT222492 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
William Okoniewski, MD 183 Southern Valley Ct, Mars, PA 16046-9329 Ph: () - | William Okoniewski, MD 1200 S Cedar Crest Blvd Fl 6, Allentown, PA 18103-6202 Ph: (610) 402-7712 |
News Archive
Scientists have known for years that the energy cost of walking and running is related primarily to the work done by muscles to lift and move the limbs.
Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online today (December 17th) in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS.
Scientists at the Institute of Molecular Biology in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA. The research on DNA demethylation sheds new light on a fundamental process that is important in development and diseases such as cancer.
Dr. Wolf M. Harmening from University Eye Hospital Bonn, together with American colleagues, studied color vision by probing individual sensory cells - photoreceptors - in the human eye.
Soligenix, Inc. a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.
› Verified 4 days ago
Dr. Ruchi Gupta, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 401 N 17th St, Suite 309, Allentown, PA 18104 Phone: 610-437-6687 | |
Dr. Douglas Mchale, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-7712 Fax: 224-484-1306 | |
Dr. Sajani Jitendra Sukhadia, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1611 Pond Rd Ste 400, Allentown, PA 18104 Phone: 610-402-8000 | |
Dr. Heather Noreen Becker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-9750 | |
Sara S Viessman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1627 W Chew St, Suite 601, Allentown, PA 18102 Phone: 610-969-2555 | |
Paige Payne, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 450 Chew St Ste 203, Allentown, PA 18102 Phone: 484-503-3058 | |
Daniel Helmut Ublagger, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd Fl 6, Allentown, PA 18103 Phone: 610-402-7712 Fax: 484-224-1306 |